4//SEC Filing
SAVIENT PHARMACEUTICALS INC 4
Accession 0001181431-13-054155
CIK 0000722104operating
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 11:20 AM ET
Size
12.6 KB
Accession
0001181431-13-054155
Insider Transaction Report
Form 4
Bahrt Kenneth
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2013-10-16$0.07/sh−1,600$116→ 106,400 total - Sale
Common Stock
2013-10-16$0.07/sh−500$36→ 100,000 total - Sale
Common Stock
2013-10-15$0.08/sh−661$54→ 111,911 total - Sale
Common Stock
2013-10-15$0.08/sh−65,639$5,336→ 112,572 total - Sale
Common Stock
2013-10-16$0.07/sh−3,500$261→ 102,900 total - Sale
Common Stock
2013-10-15$0.08/sh−3,911$322→ 108,000 total - Sale
Common Stock
2013-10-16$0.07/sh−2,400$176→ 100,500 total
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000722104
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 11:20 AM ET
- Size
- 12.6 KB